This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
John Bel Edwards has signed a series of bills into law greatly expanding patients ability to access medical cannabis products. ” Under the current law , doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer.
CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” ” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. percent in 2016).”
Medical marijuana can alleviate certain side effects and, some research indicates, reduce the number of seizures a patient experiences. It is apparent that the benefits can no longer be ignored and proper attribution can be recognized for the use of medical marijuana in the treatment of epilepsy. appeared first on.
CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments. The CDC’s interest in alternative methods of chronic pain management is likely to be of particular significance to many medical cannabis patients. percent in 2016).”
House and Senate lawmakers have approved a series of bills to facilitate patients’ access to medical cannabis products. ” Under the current law, doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .” John Bel Edwards.
In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Around 10-20% of patients stopped taking various medications (mostly antipsychotic and antiepileptic drugs) within 6 months of starting cannabis treatment.
He had never taken anti-psychotic drugs nor received psychological treatment. Due to its excellent tolerability and promising efficacy … and its innovative new mechanisms of action, we decided to offer a respective treatment with cannabidiol to [the] patient,” they write. 173,12 (2016): 1899-910. 2016, doi:10.3389/fphar.2016.00422
Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. An article published on the marijuanadoctor.com website discusses the best strains of marijuana for patients with IBS.
The Decline of Medical Marijuana in Massachusetts: What It Means for Patients In recent years, Massachusetts, once a pioneer in cannabis reform, has seen its medical marijuana program gradually overshadowed by the booming recreational market. Let’s explore how this shift occurred and its implications for patients.
Food and Drug Administration, three are prescribed for the treatment of chemotherapy-induced nausea and vomiting. In a newly published survey of 162 IBD patients in Puerto Rico, where medical cannabis is legal but recreational use is punishable with prison time , about 25% anonymously reported using cannabis to treat their symptoms.
Until now, treatment options were limited and often provided only minimal relief. However, a new, innovative study offers never-before-seen insights into the effectiveness of cannabidiol (CBD) as a promising alternative treatment option. This number has skyrocketed to 295,515 since 2020, showcasing a growing trend in the country.
The objective of the study was to examine the effectiveness of the cannabis plant (the whole dried plant) as a treatment for headache- and migraine-related pain. The study done by Sarah Stith and team, captured 1910 sessions where the 699 participants recorded using cannabis as a treatment at the actual time of headache and migraine symptoms.
As the study authors stated: The wider availability [of marijuana] means Parkinson’s patients have more of an opportunity now to experiment with it as a potential means of controlling their symptoms. However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms.
A study published earlier this year reveals a simple but interesting pattern: When patients with ADHD consume more cannabis, they require fewer prescription drugs. According to the study’s research team , patients who consume medical marijuana report a “higher occurrence of stopping all ADHD medications.”
Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. When medical cannabis was legalized in Florida in 2016, she became one of the first licensed physicians to include it in her treatment plans.
Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. 1, 2017, following a 2016 ballot measure. But do medical cannabinoids actually help animal patients? tetrahydrocannabinol without fear of sanction from the state licensing board. A simple question.
This conflict between state and federal laws limits treatment options and federal employment opportunities, particularly impacting veterans who comprise approximately one-third of the federal workforce and whose medical cannabis use to treat chronic pain and PTSD has been found to be double the rate of the general public.
An unknown number of recovered COVID-19 patients are walking through a fog, uncertain when it will end and what can be done to help. Scientists are still not sure, but one study carried out in Italy in 2020 found that out of 143 patients who had recovered from COVID-19, 87.4% How common is long COVID? episodes per month.
Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.
A 2016 article titled Cannabis sativa and Hemp by Joshua A. Another 2014 study with mice revealed that Caryophyllene can aid in the treatment of alcoholism. Through the powers of the endocannabinoid system and with the proper use of medical marijuana, patients can experience long-lasting and natural pain and symptom relief.
However, medical cannabis patients have felt somewhat neglected since The Control, Regulate and Tax Adult Use of Marijuana Act , or Proposition 64, was enacted. 8, 2016, effectively eradicated compassionate care (medical and emotional care for patients with terminal diseases).
As cannabis oil from black market is expensive and Mrdjic is poor, he started producing cannabis oil in 2016 to treat himself, his brother, who is also having epileptic attacks, and his wife, who suffers from bipolar disorder. Patients are in a terrible situation.
Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.
There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. For these famous medical cannabis patients and supporters, it is something that can improve quality of life and which should be made readily available to anyone in need. 1) Patrick Stewart. It’s tricky.”.
Approaching the topic from a medical and humane perspective, however, can help patients in need of less harmful pain and symptom relief, or provide a better lifestyle. For many patients, prescription painkillers such as opioids are prescribed to deal with the often very painful symptoms of the disease.
Unfortunately, most traditional pharmaceutical options are distinctly lacking due to side effects, as well as a bit of trepidation (although Botox, one current treatment option for migraines, has gained popularity). Patients used the app, Strainprint, which allowed data to be archived and studied.
In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% of the patients identified as white, including 96% in Maine.
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. Physicians who want to prescribe Medicinal Cannabis are required to jump through countless regulatory hoops, as are patients seeking treatment.
However, the majority of approvals have occurred since 2016. Approval and notification numbers do not equal the actual number of patients receiving these medicines under the SAS. This is because one patient can be associated with repeat applications for a single product as well as with approvals for multiple products.
But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. According to a 2016 study , about 39.3%
A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. The newsroom specifically requested aggregate data — information that would not identify individual patients.
As a part of the Arizona Medical Marijuana Act, Marijuana in Arizona can be used to treat: “A chronic or debilitating disease, medical condition or the treatment that causes: Cachexia or wasting syndrome. The biggest sign that marijuana could replace opioid painkillers for the treatment of chronic pain problems is in the statistics.
However, pharmaceutical medications can have side effects, and they may take longer to work for many patients. Bipolar Disorder May Be Treatable With Cannabis, According to a New Study New research shows that cannabis exhibits “uniquely beneficial effects” on cognitive performance and goal-directed behavior in bipolar patients.
Pennsylvania voted to legalize medical marijuana in 2016, and Pennsylvania dispensaries opened for business at the beginning of 2018. Recently, patient drives in Pennsylvania have made MMJ cards accessible to a lot of PA residents. Recently, patient drives in Pennsylvania have made MMJ cards accessible to a lot of PA residents.
The cannabis that was approved for medical use was required to have a low THC content, and patients had to register their use of the substance on the Compassionate Use Registry, arguably a violation of their privacy. The 2016 law also established more Medical Marijuana Treatment Centers, making it easier for patients to access cannabis.
who are experiencing serious thoughts of suicide increased 0.15% from 2016-2017 to 2017-2018 – an additional 460,000 people from the previous dataset. One of the major obstacles many with a mental illness face is access to and affordability of treatment and resources. According to MHA, the percentage of adults in the U.S. New Jersey.
As a growing number of states legalize medical marijuana every election season, more and more patients are making cannabis a key element of their personal treatment plans. Medical conditions similar to the ones listed above For many Florida patients dealing with the above conditions, cannabis is their preferred treatment method.
Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. When medical cannabis was legalized in Florida in 2016, she became one of the first licensed physicians to include it in her treatment plans.
Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. Shutterstock). Who can get medical cannabis in Japan? Shutterstock).
Tabling of Report on the Review into the 2016 Medicinal Cannabis amendments to the Narcotic Drugs Act 1967. Until 2016 the manufacture licensing provisions in the ND Act were applied to the control of narcotic drugs obtained from the opium poppy. 5 September 2019. Review of the operation of the medicinal cannabis scheme in the ND Act.
Medical marijuana treatment centers dispense cannabis products to patients as recommended by physicians. decrease from 2016. The state’s Office of Medical Marijuana Use shows there were 224,815 active registered medical-marijuana users in Florida in June. In 2017, there were 37,133 motor vehicle fatalities on U.S.
Now, he is the Vice-Chair of Indiana NORML — an organization who is currently focused on changing cannabis laws for the access to Medical Cannabis as therapeutic treatment in Indiana. The findings of anecdotal and controlled studies regarding the efficacy for patient use are mixed. ISNA 2020- Jason Straw- Medical Cannabis Policy.
Alzheimer’s and dementia : Preliminary research indicates that cannabinoids may have neuroprotective properties that can potentially benefit Alzheimer’s and dementia patients. A 2016 study concludes that cannabinoids can reduce inflammation and facilitate the removal of toxic proteins linked to Alzheimer’s disease.
Along with Corinne Tobias, the co-founder and program director of the Cannabis Coaching Institute, Meharg spoke with The Cannigma about the importance of cannabis coaching in this golden era of legal weed, and how their own journey as patients led them to become cannabis coaches. It was really hard to navigate even back then as a patient.”.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content